Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neurofibromatosis 1 × Neuropsychological Tests × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 4 Neoplasms 2 Breast Neoplasms 2 Sarcoma 1 Prostatic Neoplasms 1 Pituitary Neoplasms 1 Osteosarcoma 1 Oligodendroglioma 1 Neurotoxicity Syndromes 1 Neurofibromatosis 1 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Meningioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Hodgkin Disease 1 Glioma 1 Glioblastoma 1 Fatigue 1 Cytokine Release Syndrome 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Astrocytoma 1

Interventions

AZD 6244 17 trametinib 5 Lovastatin 5 Deoxycholic Acid 4 Lasers, Solid-State 3 pirfenidone 2 mirdametinib 2 fludarabine 2 binimetinib 2 Vincristine 2 Vinblastine 2 Specimen Handling 2 Sirolimus 2 Polidocanol 2 Magnetic Resonance Spectroscopy 2 Magnetic Resonance Imaging 2 Lasers 2 Lamotrigine 2 Inhalation 2 Everolimus 2 Carboplatin 2 Biopsy 2 Acetylcysteine 2 tipifarnib 1 thymoglobulin 1 talimogene laherparepvec 1 pomalidomide 1 peginterferon alfa-2b 1 omipalisib 1 lorlatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01851135 2016-07-06

NF1-QDV

Nantes University Hospital

Phase NA Completed

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡